awmsg logo



fluorouracil/salicylic acid (Actikerall®)


Reference No. 1233

Publication date:
21/06/2012


Last review date:
30/08/2016

Appraisal information

fluorouracil/salicylic acid (Actikerall®) 0.5%/10% cutaneous solution


Company: Almirall Ltd
BNF category: Skin
NMG meeting date: 28/03/2012
AWMSG meeting date: 09/05/2012
   
   
Submission Type: Limited Submission
Status: Recommended
Advice No: 1012
Ministerial ratification: 19/06/2012

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Fluorouracil/salicylic acid (Actikerall®) is recommended as an option for use within NHS Wales for the topical treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (grade I/II) in immunocompetent adult patients.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download